Follow
Preston D. Crowell
Preston D. Crowell
Scientist II, Stemson Therapeutics
Verified email at ucla.edu
Title
Cited by
Cited by
Year
Expansion of luminal progenitor cells in the aging mouse and human prostate
PD Crowell, JJ Fox, T Hashimoto, JA Diaz, HI Navarro, GH Henry, ...
Cell reports 28 (6), 1499-1510. e6, 2019
622019
CD38 is methylated in prostate cancer and regulates extracellular NAD+
J Mottahedeh, MC Haffner, TR Grogan, T Hashimoto, PD Crowell, ...
Cancer & metabolism 6, 1-17, 2018
372018
Aging of the progenitor cells that initiate prostate cancer
J Freeland, PD Crowell, JM Giafaglione, PC Boutros, AS Goldstein
Cancer Letters 515, 28-35, 2021
242021
Functional evidence that progenitor cells near sites of inflammation are precursors for aggressive prostate cancer
PD Crowell, AS Goldstein
Molecular & Cellular Oncology 4 (2), e1279723, 2017
182017
Distinct cell-types in the prostate share an aging signature suggestive of metabolic reprogramming
PD Crowell, JM Giafaglione, T Hashimoto, AS Goldstein
American Journal of Clinical and Experimental Urology 8 (4), 140, 2020
82020
Evaluating the differentiation capacity of mouse prostate epithelial cells using organoid culture
PD Crowell, JM Giafaglione, T Hashimoto, JA Diaz, AS Goldstein
JoVE (Journal of Visualized Experiments), e60223, 2019
62019
Prostate lineage-specific metabolism governs luminal differentiation and response to antiandrogen treatment
JM Giafaglione, PD Crowell, AML Delcourt, T Hashimoto, SM Ha, ...
Nature cell biology 25 (12), 1821-1832, 2023
52023
MYC is a regulator of androgen receptor inhibition-induced metabolic requirements in prostate cancer
PD Crowell, JM Giafaglione, AE Jones, NM Nunley, T Hashimoto, ...
Cell Reports 42 (10), 2023
32023
Defining regulation of prostate cancer initiation, progression, and resistance to androgen receptor blockade
PD Crowell
University of California, Los Angeles, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–9